Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$300,019,340
+$156,554,529 QoQ
Shares Held
16,035,240
+11.2% QoQ
Ownership
7.32%
of shares outstanding
% of Portfolio
15.02%
of 13F equity value
Holder Rank
#3
of 254 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $1,258,350,419 across 31 Biotechnology names. RLAY ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $482,682,924 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
This page
|
16,035,240 | $300,019,340 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $63,062,250 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,045,000 | $52,597,400 | |
| 5 | NGNE |
Neurogene Inc.
|
1,545,361 | $48,601,603 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $46,332,000 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
665,000 | $36,575,000 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
843,857 | $25,180,692 |
All Filings in RLAY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,019,340 | 16,035,240 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $143,464,811 | 14,418,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $110,010,236 | 13,003,574 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $110,010,236 | 13,003,574 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $59,202,008 | 11,341,381 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $39,439,066 | 11,398,574 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,838,263 | 9,098,574 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $36,868,124 | 8,948,574 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $65,497,844 | 9,251,108 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,084,702 | 8,448,574 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $61,615,664 | 7,423,574 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $81,341,252 | 7,387,943 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $58,227,257 | 6,923,574 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $75,342,089 | 5,998,574 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $93,855,513 | 5,698,574 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,277,881 | 3,030,648 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $104,768,373 | 4,683,432 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $68,148,614 | 4,068,574 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $115,447,582 | 3,857,253 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $118,456,239 | 3,857,253 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $115,670,138 | 3,668,574 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $123,493,372 | 3,375,058 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $116,675,755 | 3,375,058 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $158,297,634 | 3,808,894 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $162,220,795 | 3,808,894 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||